The meaning of significant mean group differences for biomarker discovery.
Ontology highlight
ABSTRACT: Over the past decade, biomarker discovery has become a key goal in psychiatry to aid in the more reliable diagnosis and prognosis of heterogeneous psychiatric conditions and the development of tailored therapies. Nevertheless, the prevailing statistical approach is still the mean group comparison between "cases" and "controls," which tends to ignore within-group variability. In this educational article, we used empirical data simulations to investigate how effect size, sample size, and the shape of distributions impact the interpretation of mean group differences for biomarker discovery. We then applied these statistical criteria to evaluate biomarker discovery in one area of psychiatric research-autism research. Across the most influential areas of autism research, effect size estimates r
SUBMITTER: Loth E
PROVIDER: S-EPMC8601419 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA